Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 221

The DOI matches its Crossref record.

Three-Year Outcome After Coronary Stenting Versus Bypass Surgery for the Treatment of Multivessel Disease

Legrand, Victor M.G., Serruys, Patrick W., Unger, Felix, van Hout, Ben A., Vrolix, Mathias C.M., Fransen, Geert M.P., Nielsen, Torsten Toftegaard, Paulsen, Peter Kildeberg, Gomes, Ricardo Seabra, de Queiroz e Melo, João M.G., Marques dos Santos Neves, José P., Lindeboom, Wietze, Backx, Bianca · 2004 · Circulation

Abstract

Background— The primary results of Arterial Revascularization Therapy Study reported a greater need for repeated revascularization after percutaneous coronary intervention with stenting (PCI). However, PCI was less expensive than coronary artery bypass grafting (CABG) and offered the same degree of protection against death, stroke, and myocardial infarction. Methods and Results— Patients with multivessel disease (n=1205) were randomly assigned to either CABG or PCI and followed up for up to 3 years. Survival rates without stroke or myocardial infarction were similar in each group at 1 year and 3 years (90.5% versus 91.4% for PCI versus CABG at 1 year and 87.2% versus 88.4% for PCI versus CABG at 3 years). However, the respective repeat revascularization rates were 21.2% and 26.7% at 1 and 3 years in patients allocated to PCI, compared with 3.8% and 6.6% in patients allocated to CABG ( P <0.0001). Diabetes ( P <0.0009) and maximal pressure for stent deployment ( P <0.002) are the strongest independent predictors of events at 3 years after PCI, whereas left anterior descending coronary artery grafting ( P <0.006) is the best predictor of event-free survival at 3 years after CABG. The incremental cost of surgery compared with PCI for an event-free patient was 19 257 at 1 year but decreased to 10 492 at 3 years. It remained at 142 391 at 3 years when revascularization procedures were excluded in the efficacy end point, however. Conclusions— Three-year survival rates without stroke and myocardial infarction are identical in both groups, and the cost/benefit ratio of stenting is determined primarily by the increasing need for revascularization in the PCI group.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.cir.0000118504.61212.4b

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 221

Metadata

Authors
Legrand, V. M. G., Serruys, P. W., Unger, F., van Hout, B. A., Vrolix, M. C. M., Fransen, G. M. P., Nielsen, T. T., Paulsen, P. K., Gomes, R. S., de Queiroz e Melo, J. M. G., Marques dos Santos Neves, J. P., Lindeboom, W., & Backx, B.
Venue
Circulation
Published
2004-03-09
Volume
109
Issue
9
Pages
1114-1120
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2141383828
Cited by
221
References
0
FWCI
31.50
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Three-Year Outcome After Coronary Stenting Versus Bypass Surgery for the Treatment of Multivessel Disease. https://app.cochat.ai/papers/10.1161/01.cir.0000118504.61212.4b
The paper
Legrand, V. M. G., Serruys, P. W., Unger, F., van Hout, B. A., Vrolix, M. C. M., Fransen, G. M. P., Nielsen, T. T., Paulsen, P. K., Gomes, R. S., de Queiroz e Melo, J. M. G., Marques dos Santos Neves, J. P., Lindeboom, W., & Backx, B. (2004). Three-Year Outcome After Coronary Stenting Versus Bypass Surgery for the Treatment of Multivessel Disease. Circulation. https://doi.org/10.1161/01.cir.0000118504.61212.4b

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.